Month: March 2025

If Sherlock Holmes was a real person, would he be able to solve the mysterious case of chemical exposure and prostate cancer? Specifically, I’m talking about the chemicals used in products that kill bugs. Can you see where I’m going with this? If some chemicals are harmful to living cells in insects, might they also keep reading

In 2020, an editorial in a medical journal observed, “As the Internet is now an established platform and easily accessible, patients are increasingly seeking information from websites out of curiosity and for additional questions pertaining to their health condition.”[i] Well, sure. What could be more efficient than sitting in front of your home or office keep reading

Okay, folks, this is BIG NEWS! A research study out of the esteemed Johns Hopkins University School of Medicine and two other academic centers may be the first of its kind to definitively connect healthy diet with reining in prostate cancer (PCa). Specifically, the study population was done with PCa patients currently on Active Surveillance keep reading

The use of 2 parameters of imaging sequences is called biparametric MRI (bpMRI) – and new research shows it could make MRI widely available as a better screening tool than the PSA test which can lead to overdiagnosis and overtreatment. Now there’s an exciting boost to the speed and accuracy of bpMRI: Deep Learning (DL), a branch of Artificial Intelligence (AI). keep reading

If you have a common aging-related enlargement of the prostate, a condition called BPH, you may have some of the problems that come with it. These are problems like more frequent nighttime peeing, more urge to pee during the day, difficulty starting urine flow, inability to completely empty your bladder, even urinary tract infections that keep reading

An essential part of planning treatment for prostate cancer (PCa) is determining its size and location. Where and how big is it? If the tumor is found early when it is small and contained within the gland, it is called localized. In this case, the patient is a candidate for a local treatment with curative keep reading

When a patient is told, “You have prostate cancer,” it’s not a simple one-size-fits-all diagnosis. The doctor will then give the patient an idea of how severe his cancer is. If his prostate cancer (PCa) is still localized (that is, contained within the gland), the doctor will specify if it is low, intermediate, or high keep reading

The strategy of using active surveillance (AS) is increasingly recommended to low-risk prostate cancer (PCa) patients as a way to avoid or delay overtreatment. This is a new way of thinking; before the New Millennium, PCa was assumed to be multi-focal and most men with more than 10 years of life expectancy were hurried into surgery or radiation. Today’s terminology includes words that might have been meaningless a decade ago, e.g. indolent cancer, very low risk disease, and focal disease are all consistent with the growing movement toward AS. keep reading

If you’re a real estate developer planning to build a new house, you start with the groundwork—literally. Before you start excavating, you have analysts determine the basics: the type of soil, the water table, and any flood risk. You want to know the important foundation factors that help predict the future stability of the construction. keep reading

We’ve said it before and we’ll say it again: exercise offers better outcomes for prostate cancer patients. This time, we’re basing our advice on an exciting development in the field of cancer research. Oncology, or the medical specialty dealing with cancer, is increasingly interested in the relationship between exercise and cancer survival. A noted authority keep reading